# OMDA (Omada Health, Inc.) - SEC EDGAR Financial Statements

> Omada Health, Inc. reported $333.0M in revenue and net income of $14.03M for the trailing twelve months ended September 30, 2026 (up 34.2% year over year), with a 70.7% gross margin and a 2.1% operating margin.

- Canonical: https://convexityos.com/fundamentals/OMDA
- Markdown: https://convexityos.com/fundamentals/OMDA.md
- SEC CIK: 0001611115
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:31 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001611115&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $333.0M | +34.2% YoY |
| Operating Income | TTM | $6.87M | 2.1% margin |
| Net Income | TTM | $14.03M | 4.2% net margin |
| Diluted EPS | TTM | $0.21 | Split-adjusted |
| Free Cash Flow | TTM | $28.15M | 8.5% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $243.2M | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| **Revenue** | $260.2M | $169.8M | $122.8M |
| Cost of Revenue | $89.27M | $66.92M | $52.81M |
| **Gross Profit** | $170.9M | $102.9M | $69.97M |
| Research & Development | $40.68M | $35.92M | $33.74M |
| Selling, General & Admin | $142.2M | $110.6M | $102.2M |
| Total Operating Expenses | $182.9M | $146.5M | $136.0M |
| **Operating Income** | -$11.97M | -$43.65M | -$66.00M |
| **EBITDA** | -$6.48M | -$38.85M | -$61.55M |
| Interest Income | $5.30M | $805K | $5.78M |
| Interest Expense | $2.53M | $4.51M | $4.71M |
| Income Before Tax | -$12.78M | -$47.14M | -$67.51M |
| Income Tax Expense | $0 | $0 | $0 |
| **Net Income** | -$12.78M | -$47.14M | -$67.51M |
| Basic EPS | -$0.35 | -$6.11 | -$9.52 |
| **Diluted EPS** | -$0.35 | -$6.11 | -$9.52 |
| Basic Shares Outstanding | 36.6M | 7.7M | 7.1M |
| Diluted Shares Outstanding | 36.6M | 7.7M | 7.1M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $91.31M | $87.83M | $78.05M | $75.85M | $68.03M | $61.37M | $54.96M | -- |
| Cost of Revenue | $22.02M | $24.05M | $29.36M | $22.18M | $22.96M | $21.07M | $23.06M | -- |
| **Gross Profit** | $69.28M | $63.79M | $48.69M | $53.66M | $45.07M | $40.31M | $31.90M | -- |
| Research & Development | $15.27M | $14.62M | $12.70M | $11.55M | $10.30M | $10.02M | $8.81M | -- |
| Selling, General & Admin | $49.19M | $45.61M | $40.78M | $38.83M | $37.28M | $34.63M | $31.49M | -- |
| Total Operating Expenses | $64.46M | $60.24M | $53.47M | $50.38M | $47.58M | $44.65M | $40.30M | -- |
| **Operating Income** | $4.82M | $3.55M | -$4.78M | $3.28M | -$2.51M | -$4.34M | -$8.40M | -- |
| **EBITDA** | $6.50M | $5.13M | -$3.27M | $4.73M | -$1.15M | -$2.99M | -$7.06M | -- |
| Interest Income | $1.99M | $1.76M | $1.83M | $1.89M | $2.01M | $863K | $542K | -- |
| Interest Expense | $262K | $14K | $18K | $13K | $353K | $1.09M | $1.07M | -- |
| Income Before Tax | $6.55M | $5.29M | -$2.97M | $5.16M | -$3.18M | -$5.31M | -$9.45M | -- |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -- |
| **Net Income** | $6.55M | $5.29M | -$2.97M | $5.16M | -$3.18M | -$5.31M | -$9.45M | -$8.25M |
| Basic EPS | $0.11 | $0.09 | -$0.05 | -- | -$0.06 | -$0.24 | -$1.15 | -- |
| **Diluted EPS** | $0.10 | $0.08 | -$0.05 | -- | -$0.06 | -$0.24 | -$1.15 | -- |
| Basic Shares Outstanding | 61.5M | 59.7M | 58.9M | -- | 57.7M | 22.0M | 8.2M | -- |
| Diluted Shares Outstanding | 67.1M | 63.9M | 58.9M | -- | 57.7M | 22.0M | 8.2M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 |
| --- | --- | --- |
| Cash & Cash Equivalents | $222.0M | $76.39M |
| **Cash & Short-Term Investments** | $222.0M | $76.39M |
| Accounts Receivable, Net | $34.59M | $23.42M |
| Inventory | $4.49M | $3.30M |
| Other Current Assets | $1.89M | $2.14M |
| **Total Current Assets** | $272.9M | $113.1M |
| Property, Plant & Equipment, Net | $7.94M | $5.62M |
| Goodwill | $13.24M | $13.24M |
| Intangible Assets | $2.41M | $4.26M |
| Other Non-Current Assets | $165K | $5.04M |
| **Total Non-Current Assets** | $32.47M | $37.83M |
| **Total Assets** | $305.4M | $150.9M |
| Accounts Payable | $10.28M | $4.17M |
| Deferred Revenue (Current) | $25.06M | $19.53M |
| **Total Current Liabilities** | $75.73M | $53.95M |
| Long-Term Debt | $0 | $29.77M |
| Other Non-Current Liabilities | $0 | $285K |
| **Total Non-Current Liabilities** | $0 | $32.31M |
| **Total Liabilities** | $75.73M | $86.26M |
| **Total Debt (incl. Leases)** | $0 | $30.19M |
| Common Stock | $58K | $8.0K |
| Retained Earnings | -$456.7M | -$444.0M |
| **Total Stockholders' Equity** | $229.7M | -$384.4M |
| Total Equity | $229.7M | -$384.4M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $243.2M | $221.7M | $211.8M | $222.0M | $198.6M | $223.1M | $76.39M |
| **Cash & Short-Term Investments** | $243.2M | $221.7M | $211.8M | $222.0M | $198.6M | $223.1M | $76.39M |
| Accounts Receivable, Net | $48.19M | $56.57M | $39.98M | $34.59M | $41.45M | $33.29M | $23.42M |
| Inventory | $4.88M | $4.12M | $3.83M | $4.49M | $3.15M | $3.47M | $3.30M |
| Other Current Assets | -- | -- | -- | $1.89M | -- | -- | $2.14M |
| **Total Current Assets** | $315.1M | $294.9M | $269.4M | $272.9M | $254.9M | $271.1M | $113.1M |
| Property, Plant & Equipment, Net | $9.74M | $9.10M | $8.46M | $7.94M | $7.54M | $6.48M | $5.62M |
| Goodwill | $13.24M | $13.24M | $13.24M | $13.24M | $13.24M | $13.24M | $13.24M |
| Intangible Assets | $1.10M | $1.54M | $1.98M | $2.41M | $2.85M | $3.29M | $4.26M |
| Other Non-Current Assets | $417K | $215K | $226K | $165K | $199K | $234K | $5.04M |
| **Total Non-Current Assets** | $33.48M | $33.31M | $33.37M | $32.47M | $32.57M | $31.87M | $37.83M |
| **Total Assets** | $348.5M | $328.2M | $302.8M | $305.4M | $287.5M | $303.0M | $150.9M |
| Accounts Payable | $8.38M | $11.80M | $8.10M | $10.28M | $5.34M | $7.40M | $4.17M |
| Deferred Revenue (Current) | $25.84M | $27.70M | $29.35M | $25.06M | $27.16M | $25.52M | $19.53M |
| **Total Current Liabilities** | $75.38M | $75.48M | $68.68M | $75.73M | $70.12M | $57.99M | $53.95M |
| Long-Term Debt | -- | -- | -- | $0 | $0 | $29.97M | $29.77M |
| Other Non-Current Liabilities | $0 | $0 | $0 | $0 | $0 | $373K | $285K |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $0 | $30.77M | $32.31M |
| **Total Liabilities** | $75.38M | $75.48M | $68.68M | $75.73M | $70.12M | $88.76M | $86.26M |
| **Total Debt (incl. Leases)** | -- | -- | -- | $0 | $0 | $29.97M | $30.19M |
| Common Stock | $62K | $61K | $59K | $58K | $58K | $56K | $8.0K |
| Retained Earnings | -$447.9M | -$454.4M | -$459.7M | -$456.7M | -$461.9M | -$458.7M | -$444.0M |
| **Total Stockholders' Equity** | $273.2M | $252.7M | $234.1M | $229.7M | $217.3M | $214.2M | -$384.4M |
| Total Equity | $273.2M | $252.7M | $234.1M | $229.7M | $217.3M | $214.2M | -$384.4M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Net Income | -$12.78M | -$47.14M | -$67.51M |
| Depreciation & Amortization | $5.49M | $4.80M | $4.45M |
| Stock-Based Compensation | $12.96M | $9.42M | $8.74M |
| Change in Receivables | -$12.36M | -$8.80M | -$5.34M |
| Change in Inventory | -$1.19M | $318K | -$74K |
| Change in Payables | $6.29M | $399K | -$286K |
| **Operating Cash Flow** | $18.25M | -$34.18M | -$49.74M |
| Capital Expenditure | -$1.32M | -$596K | -$416K |
| **Free Cash Flow** | $16.93M | -$34.77M | -$50.15M |
| **Investing Cash Flow** | -$5.83M | -$3.86M | -$2.92M |
| **Financing Cash Flow** | $133.2M | -$1.21M | $179K |
| **Net Change in Cash** | $145.6M | -$39.25M | -$52.48M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $6.55M | $5.29M | -$2.97M | $5.16M | -$3.18M | -$5.31M | -$9.45M | -$8.25M |
| Depreciation & Amortization | $1.68M | $1.58M | $1.51M | $1.45M | $1.36M | $1.35M | $1.33M | -- |
| Stock-Based Compensation | $5.85M | $5.63M | $4.21M | $3.75M | $3.54M | $2.83M | $2.84M | -- |
| Change in Receivables | $7.25M | -$16.97M | -$6.21M | $7.16M | -$9.15M | -$3.86M | -$6.50M | -- |
| Change in Inventory | -$761K | -$288K | $655K | -$1.34M | $321K | -$427K | $254K | -- |
| Change in Payables | -$3.61M | $3.65M | -$2.12M | $4.92M | $357K | $733K | $283K | -- |
| **Operating Cash Flow** | $15.14M | $4.01M | -$11.83M | $21.38M | $10.13M | $2.86M | -$16.12M | -- |
| Capital Expenditure | -$118K | -$146K | -$78K | -$199K | -$537K | -$271K | -$315K | -- |
| **Free Cash Flow** | $15.02M | $3.86M | -$11.91M | $21.18M | $9.60M | $2.59M | -$16.43M | -- |
| **Investing Cash Flow** | -$1.63M | -$1.66M | -$1.56M | -$1.35M | -$1.99M | -$1.25M | -$1.25M | -- |
| **Financing Cash Flow** | $7.93M | $7.60M | $3.12M | $3.38M | -$32.66M | $162.1M | $372K | -- |
| **Net Change in Cash** | $21.44M | $9.95M | -$10.27M | $23.41M | -$24.52M | $163.7M | -$17.00M | -- |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| **Gross Margin** | 65.7% | 60.6% | 57.0% |
| **Operating Margin** | -4.6% | -25.7% | -53.8% |
| **Net Profit Margin** | -4.9% | -27.8% | -55.0% |
| Return on Equity (ROE) | -5.6% | -- | -- |
| Return on Assets (ROA) | -4.2% | -31.2% | -- |
| Current Ratio | 3.60x | 2.10x | -- |
| Quick Ratio | 3.54x | 2.03x | -- |
| Debt to Equity | 0.00x | -- | -- |
| **Revenue Growth (YoY)** | +53.2% | +38.3% | -- |
| Gross Profit Growth (YoY) | +66.2% | +47.0% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 70.7% | 68.2% | 66.3% | 65.7% | -- | -- | -- | -- |
| **Operating Margin** | 2.1% | -0.1% | -2.9% | -4.6% | -- | -- | -- | -- |
| **Net Profit Margin** | 4.2% | 1.4% | -2.2% | -4.9% | -- | -- | -- | -- |
| Return on Equity (ROE) | 5.1% | 1.7% | -2.7% | -5.6% | -12.0% | -15.0% | -- | -- |
| Return on Assets (ROA) | 4.0% | 1.3% | -2.1% | -4.2% | -9.1% | -10.6% | -- | -31.2% |
| Current Ratio | 4.18x | 3.91x | 3.92x | 3.60x | 3.64x | 4.68x | -- | 2.10x |
| Quick Ratio | 4.11x | 3.85x | 3.87x | 3.54x | 3.59x | 4.62x | -- | 2.03x |
| Debt to Equity | -- | -- | -- | 0.00x | 0.00x | 0.14x | -- | -- |
| **Revenue Growth (YoY)** | +34.2% | +43.1% | +42.0% | -- | +49.5% | +48.9% | -- | -- |
| Gross Profit Growth (YoY) | +53.7% | +58.3% | +52.6% | -- | +57.8% | +62.3% | -- | -- |
| Operating Cash Flow Growth (YoY) | +49.4% | +40.2% | -- | -- | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | +56.5% | +49.2% | -- | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
